Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors

por Goossens, Martine, Pauwels, Katia, Willemarck, Nicolas, Breyer, Didier
Publicado 2013

Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2

por Baldo, Aline, Leunda, Amaya, Willemarck, Nicolas, Pauwels, Katia
Publicado 2021

Primary cilium suppression by SREBP1c involves distortion of vesicular trafficking by PLA2G3

por Gijs, Hannah Laura, Willemarck, Nicolas, Vanderhoydonc, Frank, Khan, Niamat Ali, Dehairs, Jonas, Derua, Rita, Waelkens, Etienne, Taketomi, Yoshitaka, Murakami, Makoto, Agostinis, Patrizia, Annaert, Wim, Swinnen, Johannes V.
Publicado 2015

Identification of drugs that restore primary cilium expression in cancer cells

por Khan, Niamat Ali, Willemarck, Nicolas, Talebi, Ali, Marchand, Arnaud, Binda, Maria Mercedes, Dehairs, Jonas, Rueda-Rincon, Natalia, Daniels, Veerle W., Bagadi, Muralidhararao, Raj, Deepak Balaji Thimiri Govinda, Vanderhoydonc, Frank, Munck, Sebastian, Chaltin, Patrick, Swinnen, Johannes V.
Publicado 2016